Brief: Adagio Medical Closes Financing of $19 Million Upfront; Positions Company to Advance Purpose-Built Technology for Treatment of Ventricular Tachycardia
20/10/2025 13:08
Oct 20 (Reuters) - Adagio Medical Holdings Inc ADGM.O: ADAGIO MEDICAL CLOSES FINANCING OF $19 MILLION UPFRONT; POSITIONS COMPANY TO ADVANCE PURPOSE-BUILT TECHNOLOGY FOR TREATMENT OF VENTRICULAR TACHYCARDIA Source text: ID:nBw9XXlSla Further company coverage: ADGM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adagio Medical Holdings
See all newsBrief: Adagio Medical Submits Premarket Approval Application To FDA For Vclas® Ventricular Ablation System
Brief: Adagio Medical Announces Positive Pivotal Results For vCLAS Ventricular Ablation System
U.S. RESEARCH ROUNDUP-Biogen, Equinix, Revolution Medicines
U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg
Adagio Medical rises after FDA clears expanded testing of heart device